中药治疗糖尿病肾病及其相关机制综述
糖尿病肾病是糖尿病常见微血管并发症,现有西药一线治疗包括RAS抑制剂或血管紧张素受体阻滞剂及最新获批的醛固酮受体拮抗剂非奈利酮,可延缓进展至终末期肾病但疗效仍不理想。本文综述中药复方、中草药及其活性成分治疗糖尿病肾病的疗效与机制研究进展。
要点
- 中药治疗糖尿病肾病基于生津养血、益气养阴、解毒消肿等治法理论。
- 中药复方、单味药及活性成分对糖尿病肾病的治疗效应与机制受到广泛关注。
- 现有西药可延缓糖尿病肾病进展至终末期肾病,但疗效仍不理想。
核心结论
- 中药在糖尿病肾病治疗中具有丰富经验,其复方、单味药及活性成分的治疗效应与机制成为新药研发关注点。
研究设计与样本
- 本文为综述,汇总中药复方、中草药及其活性成分治疗糖尿病肾病机制的研究进展。
主要发现
- 糖尿病肾病现有西药一线治疗可延缓进展至终末期肾病,但疗效仍不理想。
- 中药治疗糖尿病肾病临床主要基于生津养血、益气养阴、解毒消肿等治法理论。
临床怎么用
- 临床可基于生津养血、益气养阴、解毒消肿等中医治法理论指导糖尿病肾病的中药治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Diabetic nephropathy (DN) is a common microvascular complication of diabetes mellitus (DM), which can lead to renal failure in diabetic patients. At present, the first-line drugs for DN are mainly the renin-angiotensin system (RAS) inhibitors or angiotensin receptor blockers, and the latest approved aldosterone receptor antagonist finerenone, which delay the progression of DN to end-stage renal disease (ESRD), but the therapeutic effect is still not ideal. With a history of thousands of years, traditional Chinese medicine (TCM) has rich experience in the treatment of DN. Based on the theory of TCM, the clinical treatment of DN mainly focuses on generating fluid and nourishing blood, nourishing Qi and Yin, detoxifying and detumescent. In recently years, the therapeutic effects and mechanisms of TCM prescription, Chinese herbal medicine, and its active components on DN have received extensive attention in new drug development. This paper reviews the research progress of the mechanism of TCM on DN.
引用
- Liu XJ, Hu XK, Yang H, et al. A Review of Traditional Chinese Medicine on Treatment of Diabetic Nephropathy and the Involved Mechanisms. Am J Chin Med. 2022. PMID: 36222120. doi:10.1142/S0192415X22500744
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。